カテゴリー： Market Monitor Global, 世界, 医療/バイオ

注射用絨毛性ゴナドトロピンの世界市場見通し2023年-2029年

◆英語タイトル：Chorionic Gonadotropin for Injection Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8415 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：71 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Chorionic Gonadotropin for Injection Market 調査レポートは次の情報を含め、グローバルにおけるの注射用絨毛性ゴナドトロピン市場規模と予測を収録しています。・世界の注射用絨毛性ゴナドトロピン市場：売上、2018年-2023年、2024年-2029年
・世界の注射用絨毛性ゴナドトロピン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の注射用絨毛性ゴナドトロピン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「u-hCG」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

注射用絨毛性ゴナドトロピンのグローバル主要企業は、Shanghai Livzon Pharmaceutical Co., Ltd.、 Qingdao Guanlong Biopharmaceutical Co., Ltd.、 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.、 Ningbo Renjian Pharmaceutical Group Co., Ltd.、 Merckなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、注射用絨毛性ゴナドトロピンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の注射用絨毛性ゴナドトロピン市場：タイプ別、2018年-2023年、2024年-2029年
世界の注射用絨毛性ゴナドトロピン市場：タイプ別市場シェア、2022年
・u-hCG、r-hCG

世界の注射用絨毛性ゴナドトロピン市場：用途別、2018年-2023年、2024年-2029年
世界の注射用絨毛性ゴナドトロピン市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の注射用絨毛性ゴナドトロピン市場：地域・国別、2018年-2023年、2024年-2029年
世界の注射用絨毛性ゴナドトロピン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における注射用絨毛性ゴナドトロピンのグローバル売上、2018年-2023年
・主要企業における注射用絨毛性ゴナドトロピンのグローバル売上シェア、2022年
・主要企業における注射用絨毛性ゴナドトロピンのグローバル販売量、2018年-2023年
・主要企業における注射用絨毛性ゴナドトロピンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Shanghai Livzon Pharmaceutical Co., Ltd.、 Qingdao Guanlong Biopharmaceutical Co., Ltd.、 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.、 Ningbo Renjian Pharmaceutical Group Co., Ltd.、 Merck

*************************************************************

・調査・分析レポートの概要
注射用絨毛性ゴナドトロピン市場の定義
市場セグメント
世界の注射用絨毛性ゴナドトロピン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の注射用絨毛性ゴナドトロピン市場規模
世界の注射用絨毛性ゴナドトロピン市場規模：2022年 VS 2029年
世界の注射用絨毛性ゴナドトロピン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの注射用絨毛性ゴナドトロピンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の注射用絨毛性ゴナドトロピン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：u-hCG、r-hCG
注射用絨毛性ゴナドトロピンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
注射用絨毛性ゴナドトロピンの用途別グローバル売上・予測

・地域別市場分析
地域別注射用絨毛性ゴナドトロピン市場規模 2022年と2029年
地域別注射用絨毛性ゴナドトロピン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Shanghai Livzon Pharmaceutical Co., Ltd.、 Qingdao Guanlong Biopharmaceutical Co., Ltd.、 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.、 Ningbo Renjian Pharmaceutical Group Co., Ltd.、 Merck
...

This report aims to provide a comprehensive presentation of the global market for Chorionic Gonadotropin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chorionic Gonadotropin for Injection. This report contains market size and forecasts of Chorionic Gonadotropin for Injection in global, including the following market information:
Global Chorionic Gonadotropin for Injection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Chorionic Gonadotropin for Injection Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Chorionic Gonadotropin for Injection companies in 2022 (%)
The global Chorionic Gonadotropin for Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
u-hCG Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chorionic Gonadotropin for Injection include Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd. and Merck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chorionic Gonadotropin for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chorionic Gonadotropin for Injection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Chorionic Gonadotropin for Injection Market Segment Percentages, by Type, 2022 (%)
u-hCG
r-hCG
Global Chorionic Gonadotropin for Injection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Chorionic Gonadotropin for Injection Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Chorionic Gonadotropin for Injection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Chorionic Gonadotropin for Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chorionic Gonadotropin for Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Chorionic Gonadotropin for Injection revenues share in global market, 2022 (%)
Key companies Chorionic Gonadotropin for Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Chorionic Gonadotropin for Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shanghai Livzon Pharmaceutical Co., Ltd.
Qingdao Guanlong Biopharmaceutical Co., Ltd.
Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chorionic Gonadotropin for Injection, market overview.
Chapter 2: Global Chorionic Gonadotropin for Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Chorionic Gonadotropin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chorionic Gonadotropin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chorionic Gonadotropin for Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Chorionic Gonadotropin for Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chorionic Gonadotropin for Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chorionic Gonadotropin for Injection Overall Market Size
2.1 Global Chorionic Gonadotropin for Injection Market Size: 2022 VS 2029
2.2 Global Chorionic Gonadotropin for Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Chorionic Gonadotropin for Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Chorionic Gonadotropin for Injection Players in Global Market
3.2 Top Global Chorionic Gonadotropin for Injection Companies Ranked by Revenue
3.3 Global Chorionic Gonadotropin for Injection Revenue by Companies
3.4 Global Chorionic Gonadotropin for Injection Sales by Companies
3.5 Global Chorionic Gonadotropin for Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chorionic Gonadotropin for Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chorionic Gonadotropin for Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chorionic Gonadotropin for Injection Players in Global Market
3.8.1 List of Global Tier 1 Chorionic Gonadotropin for Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Chorionic Gonadotropin for Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Chorionic Gonadotropin for Injection Market Size Markets, 2022 & 2029
4.1.2 u-hCG
4.1.3 r-hCG
4.2 By Type – Global Chorionic Gonadotropin for Injection Revenue & Forecasts
4.2.1 By Type – Global Chorionic Gonadotropin for Injection Revenue, 2018-2023
4.2.2 By Type – Global Chorionic Gonadotropin for Injection Revenue, 2024-2029
4.2.3 By Type – Global Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Chorionic Gonadotropin for Injection Sales & Forecasts
4.3.1 By Type – Global Chorionic Gonadotropin for Injection Sales, 2018-2023
4.3.2 By Type – Global Chorionic Gonadotropin for Injection Sales, 2024-2029
4.3.3 By Type – Global Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
4.4 By Type – Global Chorionic Gonadotropin for Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Chorionic Gonadotropin for Injection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Chorionic Gonadotropin for Injection Revenue & Forecasts
5.2.1 By Application – Global Chorionic Gonadotropin for Injection Revenue, 2018-2023
5.2.2 By Application – Global Chorionic Gonadotropin for Injection Revenue, 2024-2029
5.2.3 By Application – Global Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Chorionic Gonadotropin for Injection Sales & Forecasts
5.3.1 By Application – Global Chorionic Gonadotropin for Injection Sales, 2018-2023
5.3.2 By Application – Global Chorionic Gonadotropin for Injection Sales, 2024-2029
5.3.3 By Application – Global Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
5.4 By Application – Global Chorionic Gonadotropin for Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Chorionic Gonadotropin for Injection Market Size, 2022 & 2029
6.2 By Region – Global Chorionic Gonadotropin for Injection Revenue & Forecasts
6.2.1 By Region – Global Chorionic Gonadotropin for Injection Revenue, 2018-2023
6.2.2 By Region – Global Chorionic Gonadotropin for Injection Revenue, 2024-2029
6.2.3 By Region – Global Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Chorionic Gonadotropin for Injection Sales & Forecasts
6.3.1 By Region – Global Chorionic Gonadotropin for Injection Sales, 2018-2023
6.3.2 By Region – Global Chorionic Gonadotropin for Injection Sales, 2024-2029
6.3.3 By Region – Global Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Chorionic Gonadotropin for Injection Revenue, 2018-2029
6.4.2 By Country – North America Chorionic Gonadotropin for Injection Sales, 2018-2029
6.4.3 US Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.4.4 Canada Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.4.5 Mexico Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Chorionic Gonadotropin for Injection Revenue, 2018-2029
6.5.2 By Country – Europe Chorionic Gonadotropin for Injection Sales, 2018-2029
6.5.3 Germany Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.5.4 France Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.5.5 U.K. Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.5.6 Italy Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.5.7 Russia Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.5.8 Nordic Countries Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.5.9 Benelux Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Chorionic Gonadotropin for Injection Revenue, 2018-2029
6.6.2 By Region – Asia Chorionic Gonadotropin for Injection Sales, 2018-2029
6.6.3 China Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.6.4 Japan Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.6.5 South Korea Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.6.6 Southeast Asia Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.6.7 India Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Chorionic Gonadotropin for Injection Revenue, 2018-2029
6.7.2 By Country – South America Chorionic Gonadotropin for Injection Sales, 2018-2029
6.7.3 Brazil Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.7.4 Argentina Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Chorionic Gonadotropin for Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Chorionic Gonadotropin for Injection Sales, 2018-2029
6.8.3 Turkey Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.8.4 Israel Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Chorionic Gonadotropin for Injection Market Size, 2018-2029
6.8.6 UAE Chorionic Gonadotropin for Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Shanghai Livzon Pharmaceutical Co., Ltd.
7.1.1 Shanghai Livzon Pharmaceutical Co., Ltd. Company Summary
7.1.2 Shanghai Livzon Pharmaceutical Co., Ltd. Business Overview
7.1.3 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Major Product Offerings
7.1.4 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales and Revenue in Global (2018-2023)
7.1.5 Shanghai Livzon Pharmaceutical Co., Ltd. Key News & Latest Developments
7.2 Qingdao Guanlong Biopharmaceutical Co., Ltd.
7.2.1 Qingdao Guanlong Biopharmaceutical Co., Ltd. Company Summary
7.2.2 Qingdao Guanlong Biopharmaceutical Co., Ltd. Business Overview
7.2.3 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Major Product Offerings
7.2.4 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales and Revenue in Global (2018-2023)
7.2.5 Qingdao Guanlong Biopharmaceutical Co., Ltd. Key News & Latest Developments
7.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
7.3.1 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Company Summary
7.3.2 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Business Overview
7.3.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Major Product Offerings
7.3.4 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Sales and Revenue in Global (2018-2023)
7.3.5 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Key News & Latest Developments
7.4 Ningbo Renjian Pharmaceutical Group Co., Ltd.
7.4.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Summary
7.4.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Business Overview
7.4.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Major Product Offerings
7.4.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Sales and Revenue in Global (2018-2023)
7.4.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Chorionic Gonadotropin for Injection Major Product Offerings
7.5.4 Merck Chorionic Gonadotropin for Injection Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
8 Global Chorionic Gonadotropin for Injection Production Capacity, Analysis
8.1 Global Chorionic Gonadotropin for Injection Production Capacity, 2018-2029
8.2 Chorionic Gonadotropin for Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Chorionic Gonadotropin for Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chorionic Gonadotropin for Injection Supply Chain Analysis
10.1 Chorionic Gonadotropin for Injection Industry Value Chain
10.2 Chorionic Gonadotropin for Injection Upstream Market
10.3 Chorionic Gonadotropin for Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chorionic Gonadotropin for Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Chorionic Gonadotropin for Injection in Global Market
Table 2. Top Chorionic Gonadotropin for Injection Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Chorionic Gonadotropin for Injection Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Chorionic Gonadotropin for Injection Revenue Share by Companies, 2018-2023
Table 5. Global Chorionic Gonadotropin for Injection Sales by Companies, (K Units), 2018-2023
Table 6. Global Chorionic Gonadotropin for Injection Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Chorionic Gonadotropin for Injection Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Chorionic Gonadotropin for Injection Product Type
Table 9. List of Global Tier 1 Chorionic Gonadotropin for Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chorionic Gonadotropin for Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Chorionic Gonadotropin for Injection Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Chorionic Gonadotropin for Injection Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Chorionic Gonadotropin for Injection Sales (K Units), 2018-2023
Table 15. By Type - Global Chorionic Gonadotropin for Injection Sales (K Units), 2024-2029
Table 16. By Application – Global Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Chorionic Gonadotropin for Injection Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Chorionic Gonadotropin for Injection Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Chorionic Gonadotropin for Injection Sales (K Units), 2018-2023
Table 20. By Application - Global Chorionic Gonadotropin for Injection Sales (K Units), 2024-2029
Table 21. By Region – Global Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Chorionic Gonadotropin for Injection Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Chorionic Gonadotropin for Injection Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Chorionic Gonadotropin for Injection Sales (K Units), 2018-2023
Table 25. By Region - Global Chorionic Gonadotropin for Injection Sales (K Units), 2024-2029
Table 26. By Country - North America Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Chorionic Gonadotropin for Injection Sales, (K Units), 2018-2023
Table 29. By Country - North America Chorionic Gonadotropin for Injection Sales, (K Units), 2024-2029
Table 30. By Country - Europe Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Chorionic Gonadotropin for Injection Sales, (K Units), 2018-2023
Table 33. By Country - Europe Chorionic Gonadotropin for Injection Sales, (K Units), 2024-2029
Table 34. By Region - Asia Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Chorionic Gonadotropin for Injection Sales, (K Units), 2018-2023
Table 37. By Region - Asia Chorionic Gonadotropin for Injection Sales, (K Units), 2024-2029
Table 38. By Country - South America Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Chorionic Gonadotropin for Injection Sales, (K Units), 2018-2023
Table 41. By Country - South America Chorionic Gonadotropin for Injection Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Chorionic Gonadotropin for Injection Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Chorionic Gonadotropin for Injection Sales, (K Units), 2024-2029
Table 46. Shanghai Livzon Pharmaceutical Co., Ltd. Company Summary
Table 47. Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Offerings
Table 48. Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Shanghai Livzon Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 50. Qingdao Guanlong Biopharmaceutical Co., Ltd. Company Summary
Table 51. Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Offerings
Table 52. Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Qingdao Guanlong Biopharmaceutical Co., Ltd. Key News & Latest Developments
Table 54. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Company Summary
Table 55. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Product Offerings
Table 56. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Key News & Latest Developments
Table 58. Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Summary
Table 59. Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Product Offerings
Table 60. Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Ningbo Renjian Pharmaceutical Group Co., Ltd. Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Chorionic Gonadotropin for Injection Product Offerings
Table 64. Merck Chorionic Gonadotropin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Chorionic Gonadotropin for Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Chorionic Gonadotropin for Injection Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Chorionic Gonadotropin for Injection Production by Region, 2018-2023 (K Units)
Table 69. Global Chorionic Gonadotropin for Injection Production by Region, 2024-2029 (K Units)
Table 70. Chorionic Gonadotropin for Injection Market Opportunities & Trends in Global Market
Table 71. Chorionic Gonadotropin for Injection Market Drivers in Global Market
Table 72. Chorionic Gonadotropin for Injection Market Restraints in Global Market
Table 73. Chorionic Gonadotropin for Injection Raw Materials
Table 74. Chorionic Gonadotropin for Injection Raw Materials Suppliers in Global Market
Table 75. Typical Chorionic Gonadotropin for Injection Downstream
Table 76. Chorionic Gonadotropin for Injection Downstream Clients in Global Market
Table 77. Chorionic Gonadotropin for Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chorionic Gonadotropin for Injection Segment by Type in 2022
Figure 2. Chorionic Gonadotropin for Injection Segment by Application in 2022
Figure 3. Global Chorionic Gonadotropin for Injection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chorionic Gonadotropin for Injection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chorionic Gonadotropin for Injection Revenue, 2018-2029 (US$, Mn)
Figure 7. Chorionic Gonadotropin for Injection Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chorionic Gonadotropin for Injection Revenue in 2022
Figure 9. By Type - Global Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
Figure 11. By Type - Global Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
Figure 12. By Type - Global Chorionic Gonadotropin for Injection Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
Figure 15. By Application - Global Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
Figure 16. By Application - Global Chorionic Gonadotropin for Injection Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Chorionic Gonadotropin for Injection Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
Figure 20. By Region - Global Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
Figure 21. By Country - North America Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
Figure 22. By Country - North America Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
Figure 23. US Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
Figure 28. Germany Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 29. France Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
Figure 37. China Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 41. India Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
Figure 43. By Country - South America Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
Figure 44. Brazil Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Chorionic Gonadotropin for Injection Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Chorionic Gonadotropin for Injection Sales Market Share, 2018-2029
Figure 48. Turkey Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Chorionic Gonadotropin for Injection Revenue, (US$, Mn), 2018-2029
Figure 52. Global Chorionic Gonadotropin for Injection Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Chorionic Gonadotropin for Injection by Region, 2022 VS 2029
Figure 54. Chorionic Gonadotropin for Injection Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 注射用絨毛性ゴナドトロピンの世界市場見通し2023年-2029年(Chorionic Gonadotropin for Injection Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

注射用絨毛性ゴナドトロピンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp